Your browser doesn't support javascript.
A Bright Outlook
Pharmaceutical Technology Europe ; 33(1):6, 2021.
Article in English | ProQuest Central | ID: covidwho-20243752
ABSTRACT
Bolstered by the increased public awareness of healthcare, expanding government activity-particularly in the vaccine sector-and rapid actions taken by bio/pharma companies in reaction to the pandemic, the pharma industry is expected to experience continued growth in 2021. "The industry will continue to benefit from favourable demographic and lifestyle factors, innovations, and a diminishing threat from expiring patents in addition to the shot in the arm for the whole sector from the COVID-19 pandemic, whose impact goes beyond the vaccines," said Olaf Tblke, head of corporate ratings at Scope and lead healthcare-sector analyst, in a press release (1). According to recent insight from McKinsey, M&A is a critical aspect to a pharmaceutical company's recovery within the new normal (3).
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines Language: English Journal: Pharmaceutical Technology Europe Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Topics: Vaccines Language: English Journal: Pharmaceutical Technology Europe Year: 2021 Document Type: Article